Can BioSAXS detect ultrastructural changes of antifungal compounds in Candida albicans?-an exploratory study

• Κύριοι συγγραφείς: Kai Hilpert (Συγγραφέας), Christoph Rumancev (Συγγραφέας), Jurnorain Gani (Συγγραφέας), Dominic W. P. Collis (Συγγραφέας), Paula Matilde Lopez-Perez (Συγγραφέας), Vasil M. Garamus (Συγγραφέας), Ralf Mikut (Συγγραφέας), Axel Rosenhahn (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Frontiers Media S.A., 2023-07-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

The opportunistic yeast Candida albicans is the most common cause of candidiasis. With only four classes of antifungal drugs on the market, resistance is becoming a problem in the treatment of fungal infections, especially in immunocompromised patients. The development of novel antifungal drugs with...